Literature DB >> 26566596

Seasonal influenza immunization program outside general practice: An evaluation.

Sally Morrison-Griffiths1, Liz Gaulton2.   

Abstract

With the support of our local Public Health and NHS England teams, we developed a pathway of care to provide seasonal influenza vaccination to our heroin dependent service users. 340 of the 515 service users receiving opioid substitution treatment (OST) were offered the vaccination in the 2014/15 influenza season and 205 accepted it. A further 29 service users received the vaccination elsewhere. With over 50% of those on OST prescriptions known to have a diagnosed chronic condition, such as liver or respiratory disease, this was a worthwhile health intervention in a population that is known to be "hard to reach." In addition to the potential benefit to the individuals who received the seasonal influenza vaccination, there was also an opportunity to provide health advice and information surrounding chronic disease management. Service user feedback overwhelmingly supported the provision of seasonal influenza vaccination within Drug and Alcohol services.

Entities:  

Keywords:  chronic disease; drug users; immunisation; influenza

Mesh:

Substances:

Year:  2016        PMID: 26566596      PMCID: PMC4962725          DOI: 10.1080/21645515.2015.1099770

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  2 in total

1.  Inequalities in uptake of influenza vaccine by deprivation and risk group: time trends analysis.

Authors:  Carol Coupland; Sally Harcourt; Yana Vinogradova; Gillian Smith; Carol Joseph; Mike Pringle; Julia Hippisley-Cox
Journal:  Vaccine       Date:  2007-09-05       Impact factor: 3.641

2.  Immunogenicity of influenza vaccine (1993-94 winter season) in HIV-seropositive and -seronegative ex-intravenous drug users.

Authors:  A M Iorio; A Alatri; D Francisci; R Preziosi; M Neri; I Donatelli; M R Castrucci; L R Biasio; C Tascini; R Iapoce; P Pierucci; F Baldelli
Journal:  Vaccine       Date:  1997-01       Impact factor: 3.641

  2 in total
  2 in total

1.  Immunogenicity and safety of a novel seasonal influenza preservative-free vaccine manufactured in Kazakhstan: Results of a randomized, comparative, phase II clinical trial in adults.

Authors:  Gulbanu Sarsenbayeva; Yevgeniy Volgin; Markhabat Kassenov; Timur Issagulov; Nikolay Bogdanov; Abylay Sansyzbay; Marina Stukova; Zhanna Buzitskaya; Ilyas Кulmagambetov; Timur Davlyatshin; Berik Khairullin
Journal:  Hum Vaccin Immunother       Date:  2017-12-12       Impact factor: 3.452

2.  Safety and immunogenicity of trivalent inactivated influenza vaccine in adults 60 years of age and older: a phase II, a randomized, comparative trial in Kazakhstan.

Authors:  Gulbanu Sarsenbayeva; Timur Issagulov; Markhabat Kassenov; Ruslan Abitay; Mukhit Orynbayev; Marina Stukova; Maria Pisareva; Timur Davlyatshin; Kutumbetov Lespek; Berik Khairullin
Journal:  Hum Vaccin Immunother       Date:  2020-02-12       Impact factor: 3.452

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.